Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of target site enhancer of rs2280496 or rs189178649

An enhancer and target site technology, applied in the field of biomedicine, can solve problems that cannot fully explain the reasons for platinum drug resistance

Inactive Publication Date: 2021-03-19
XIANGYA HOSPITAL CENT SOUTH UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Many studies have reported SNPs associated with sensitivity to platinum-based chemotherapy in non-small cell lung cancer, but these SNPs cannot fully explain the cause of platinum-based drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of target site enhancer of rs2280496 or rs189178649
  • Application of target site enhancer of rs2280496 or rs189178649
  • Application of target site enhancer of rs2280496 or rs189178649

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] Genome-wide study of sensitivity to platinum-based chemotherapy in non-small cell lung cancer

[0021] We first collected 17 platinum-based chemotherapy-sensitive patients and 17 chemotherapy-resistant patients ( image 3 ) for whole exome sequencing (WES) ( figure 1 a), and the sites with a p-value less than 0.001 in the difference analysis were among 262 non-small cell lung cancer patients with chemotherapy efficacy evaluation ( image 3 ) for verification, the results showed that the rs2293106 gene polymorphism was significantly correlated with the sensitivity to platinum-based chemotherapy in non-small cell lung cancer ( Figure 5 ).

[0022] Meanwhile, in 206 chemotherapy-sensitive and 227 chemotherapy-resistant NSCLC samples ( Figure 4 ) was performed in a genome-wide association analysis (GWAS) ( figure 1 b), and the non-small cell lung cancer platinum-based chemotherapy samples with chemotherapy efficacy evaluation in 347 cases of differential genes ( Fig...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

In order to solve the problem of clinical platinum chemotherapy drug resistance of non small cell lung cancer (NSCLC) at present, the invention provides application of a target site enhancer of rs2280496 or rs189178649 in preparation of a platinum chemotherapy sensitization drug for treating NSCLC, and further, the platinum chemotherapy sensitization drug is cis-platinum. The target site enhancercan be used as a novel therapeutic drug for overcoming platinum chemotherapy drug resistance.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to the role of gene rs2280496 or rs189178649 as a target in the preparation of platinum chemotherapy sensitizing drugs for treating non-small cell lung cancer. Background technique [0002] Lung cancer is a common tumor that endangers human life and health in my country and the world. Its morbidity and mortality have been ranking first among all kinds of tumors in recent decades. About 1.6 million people die of lung cancer in the world every year. Lung cancer accounts for about 22.7% of the national cancer deaths in my country. Lung cancer is divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), of which non-small cell lung cancer accounts for about 80%-85% of the total. A lot of research has been done to improve the treatment efficacy of non-small cell lung cancer, but its The 5-year survival rate is still less than 15%. In recent years...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K33/243A61K31/555A61P35/00A61P11/00
CPCA61K45/00A61K33/243A61K31/555A61P35/00A61P11/00
Inventor 陈娟刘俊彦茆晨雪刘昭前尹继业王展
Owner XIANGYA HOSPITAL CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com